Login to Your Account

Evotec, Harvard Join Forces Again in Kidney Disease Pact

By Cormac Sheridan
BioWorld International Correspondent

Wednesday, January 18, 2012
Evotec AG entered its second scientific discovery collaboration with Harvard University inside a year. The company is teaming up with Harvard scientists Andy McMahon and Ben Humphreys on an initiative called CureNephron to identify novel targets – and drugs acting on them – that have disease-modifying potential in a range of kidney indications.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription